Pharsight

Hope Pharms patents expiration

1. Nithiodote patents expiration

NITHIODOTE's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9345724 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(6 years from now)

US9585912 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(6 years from now)

US8496973 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Mar, 2031

(7 years from now)

US8568793 HOPE PHARMS Sodium nitrite-containing pharmaceutical compositions
Dec, 2031

(8 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9687506 HOPE PHARMS Sodium nitrite-containing pharmaceutical compositions
Feb, 2030

(6 years from now)

US10479686 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(6 years from now)

Drugs and Companies using SODIUM NITRITE; SODIUM THIOSULFATE ingredient

Market Authorisation Date: 14 January, 2011

Treatment: Sodium nitrite injection is administered by intravenous injection; Sodium nitrite injection is indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning; Sodium...

Dosage: SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS

More Information on Dosage

NITHIODOTE family patents

Family Patents

2. Sodium Nitrite patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8568793 HOPE PHARMS Sodium nitrite-containing pharmaceutical compositions
Dec, 2031

(8 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9687506 HOPE PHARMS Sodium nitrite-containing pharmaceutical compositions
Feb, 2030

(6 years from now)

Drugs and Companies using SODIUM NITRITE ingredient

Market Authorisation Date: 14 February, 2012

Treatment: Sodium nitrite injection is administered by intravenous injection; Sodium nitrite injection is indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

SODIUM NITRITE family patents

Family Patents

3. Sodium Thiosulfate patents expiration

SODIUM THIOSULFATE's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9345724 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(6 years from now)

US9585912 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(6 years from now)

US8496973 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Mar, 2031

(7 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10479686 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(6 years from now)

Drugs and Companies using SODIUM THIOSULFATE ingredient

Market Authorisation Date: 14 February, 2012

Treatment: Sodium thiosulfate injection is administered by intravenous injection; Sodium thiosulfate injection is indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning; Tr...

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of SODIUM THIOSULFATE before it's drug patent expiration?
More Information on Dosage

SODIUM THIOSULFATE family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic